세계의 생물학적 데이터 시각화 시장 : 규모, 점유율, 동향 분석 보고서 - 기술별, 플랫폼별, 용도별, 최종 용도별, 지역별 전망과 예측(2024-2031년)

The Global Biological Data Visualization Market size is expected to reach $1.1 billion by 2031, rising at a market growth of 8.2% CAGR during the forecast period.

MRI is a crucial non-invasive imaging technique widely used in medical diagnostics, particularly for imaging soft tissues in the brain, spine, and joints. The demand for advanced MRI visualization tools is growing due to their ability to provide high-resolution, 3D images for more precise diagnostics and treatment planning. Hence, in 2023, the magnetic resonance imaging (MRI) segment held nearly 1/5th revenue share in the market. Integrating AI and machine learning into MRI visualization software further enhances image quality, aids in automating analyses, and improves decision-making, driving market growth in this segment.

The major strategies followed by the market participants are Product Launches as the key developmental strategy to keep pace with the changing demands of end users. For instance, In February, 2024, Revvity, Inc. launched the Signals Clinical(TM) solution, an end-to-end clinical data science platform designed to centralize clinical trial data for faster, data-driven decisions. Integrated with Spotfire(R) visual analytics, the platform enables seamless data visualization, empowering quicker clinical insights and advancing drug development. Additionally, In October, 2023, Illumina, Inc. introduced the TruSight(TM) Software Suite, a solution designed to enhance the identification of genetic diseases using whole-genome sequencing. Developed in collaboration with Mayo Clinic, this software streamlines the process of analyzing genetic variants, reducing interpretation time from weeks to hours. TruSight Software aims to improve rare disease diagnostics, addressing high costs and lengthy diagnostic odysseys by enabling faster, more accurate genetic analysis.

Based on the Analysis presented in the KBV Cardinal matrix; Thermo Fisher Scientific Inc. is the forerunner in the Biological Data Visualization Market. In October, 2024, Thermo Fisher Scientific launched Amira-Avizo Software, a robust visualization solution for core imaging facilities. This software provides 2D-5D imaging capabilities, facilitating comprehensive data analysis and visualization across life sciences, materials science, and natural sciences. Companies such as Carl Zeiss AG, Agilent Technologies, Inc. and Olympus Corporation are some of the key innovators in Biological Data Visualization Market.

COVID-19 Impact Analysis

The COVID-19 outbreak highlighted the importance of bioinformatics in understanding viruses and diseases, resulting in an increased reliance on biological data visualization platforms to analyze genomic data and track virus mutations. The urgent need for real-time analysis of COVID-19-related data, such as infection rates, hospital capacities, and vaccination coverage, created a demand for dynamic biological data visualization tools capable of representing real-time updates and trends. Thus, the COVID-19 pandemic had a positive impact on the market.

Market Growth Factors

Integrating multi-omics data is crucial for advancing personalized medicine and improving therapeutic outcomes. As omics technologies continue to develop, the need for more sophisticated visualization tools becomes essential. Tools capable of visualizing large, high-dimensional data will play a key role in enabling breakthroughs in genomics, cancer research, and other complex biological fields, driving demand for biological data visualization solutions. Thus, expansion of omics technologies and integration of multi-omics data is driving the growth of the market.

The aging global population and the increasing prevalence of chronic diseases like cancer and cardiovascular disorders are amplifying the demand for efficient data interpretation. The ability to quickly and accurately interpret biological data can significantly enhance treatment outcomes and optimize healthcare processes, leading to broader adoption of biological data visualization in healthcare systems. In conclusion, rising demand for efficient data interpretation in healthcare is driving the growth of the market.

Market Restraining Factors

The financial and technical barriers to adopting advanced visualization tools greatly restrain their widespread use, especially in regions or organizations with limited research and technological investment resources. This can slow the market's overall growth for biological data visualization tools. In conclusion, high cost and complexity of implementing advanced visualization tools is impeding the growth of the market.

Technique Outlook

Based on technique, the market is divided into sequencing, microscopy, magnetic resonance imaging (MRI), x-ray crystallography, and others. The microscopy segment procured 21% revenue share in the market in 2023. Microscopy techniques, including electron and fluorescence microscopy, are critical in visualizing cellular structures and biological processes at a microscopic level. Visualization software enhances image clarity, accuracy, and analysis, enabling scientists to study intricate biological phenomena.

Platform Outlook

On the basis of platform, the market is segmented into Windows, Mac OS, Linux, and others. The Windows segment recorded 56% revenue share in the market in 2023. Windows remains the dominant platform for biological data visualization due to its widespread use in the research and healthcare sectors. Many biological data visualization tools and software are optimized for Windows, providing researchers with powerful, user-friendly interfaces for processing and visualizing complex biological data.

Application Outlook

Based on application, the market is categorized into cell & organism imaging, alignment, phylogeny, & evolution, genomic analysis, system biology, and structural biology & molecular modeling. The alignment, phylogeny, & evolution segment witnessed 23% revenue share in the market in 2023. This segment analyzes evolutionary relationships and genetic alignments, helping researchers visualize the genetic connections between species, populations, and individuals. Tools for phylogenetic tree construction, gene sequence alignment, and evolutionary modelling are in high demand, particularly in evolutionary biology, anthropology, and biodiversity studies.

End Use Outlook

By end use, the market is divided into academic research, pharmaceutical & biotechnology companies, hospitals & clinics, and others. In 2023, the academic research segment registered 63% revenue share in the market. Academic research remains the dominant driver of demand for biological data visualization tools, as researchers across universities, research institutes, and laboratories heavily rely on advanced visualization methods to analyze and interpret biological data. This includes the visualization of genetic sequences, protein structures, cellular behavior, and imaging data, which are critical for various fields of biological science.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region witnessed 42% revenue share in the market in 2023. North America remains the dominant market due to the strong presence of advanced research facilities, universities, pharmaceutical and biotechnology companies, and healthcare institutions. The region is home to leading players in the biological data visualization industry, driving the adoption of innovative technologies in research and clinical applications.

Recent Strategies Deployed in the Market

• Jul-2024: Oxford Instruments plc has completed the acquisition of FemtoTools AG, a Swiss company specializing in nanoindentation for material properties analysis. This acquisition enhances Oxford Instruments' Imaging & Analysis division, integrating FemtoTools' technology with their existing range of materials analysis tools, including electron microscopes and Raman microscopes.
• Apr-2024: Carl Zeiss AG formed a partnership with Argolight, a French company specializing in quality control solutions for microscopy. This collaboration integrates Argolight's advanced calibration and quality control tools with Zeiss' microscopy systems, enhancing the performance measurement and imaging accuracy for users. The partnership aims to provide superior reliability and reproducibility in scientific research, industrial processes, and medical diagnostics.
• Oct-2023: Revvity, Inc. collaborated with Element Biosciences, a developer of the AVITI(TM) System, an advanced genomic sequencing platform, to streamline genomic analysis workflows. This collaboration combines Revvity's tools for sample collection, nucleic acid extraction, and data analysis with Element's flexible AVITI System, enhancing the efficiency and accessibility of genomic sequencing. The integrated solution aims to support labs in advancing scientific research and improving genomic data applications.
• Oct-2023: Carl Zeiss AG entered a long-term collaboration with Boehringer Ingelheim, a leading biopharmaceutical company, to develop predictive analytics for early detection of eye diseases. The collaboration will leverage ZEISS Medical Technology's cloud-connected devices and AI-assisted analysis to identify early-stage retinal diseases, aiming for personalized treatments to preserve vision. Boehringer Ingelheim focuses on breakthrough therapies, targeting retinal conditions such as inflammation and neuroprotection.
• Jun-2023: Revvity, Inc. launched the Signals Research Suite, a cloud-native SaaS platform integrating biology, chemistry, and materials new product development workflows. This unified solution enhances collaboration across R&D disciplines, offering advanced analytics and visualizations powered by TIBCO Spotfire(R) to support the entire drug discovery and materials development lifecycle. Revvity provides health science solutions and informatics to accelerate insights and improve decision-making in drug development.

List of Key Companies Profiled

• Thermo Fisher Scientific Inc.
• 3M Company
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Illumina, Inc.
• Revvity, Inc.
• Qiagen N.V
• Carl Zeiss AG
• Oxford Instruments plc
• Olympus Corporation

Global Biological Data Visualization Market Report Segmentation

By Technique

• Sequencing
• Microscopy
• Magnetic Resonance Imaging (MRI)
• X-ray Crystallography
• Other Technique

By Platform

• Windows
• Mac OS
• Linux
• Other Platform

By Application

• Cell & Organism Imaging
• Alignment, Phylogeny, & Evolution
• Genomic Analysis
• System Biology
• Structural Biology & Molecular Modeling

By End Use

• Academic Research
• Pharmaceutical & Biotechnology Companies
• Hospitals & Clinics
• Other End Use

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Biological Data Visualization Market, by Technique
  • 1.4.2 Global Biological Data Visualization Market, by Platform
  • 1.4.3 Global Biological Data Visualization Market, by Application
  • 1.4.4 Global Biological Data Visualization Market, by End Use
  • 1.4.5 Global Biological Data Visualization Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market at a Glance

• 2.1 Key Highlights

Chapter 3. Market Overview

• 3.1 Introduction
  • 3.1.1 Overview
    • 3.1.1.1 Market Composition and Scenario
• 3.2 Key Factors Impacting the Market
  • 3.2.1 Market Drivers
  • 3.2.2 Market Restraints
  • 3.2.3 Market Opportunities
  • 3.2.4 Market Challenges

Chapter 4. Competition Analysis - Global

• 4.1 KBV Cardinal Matrix
• 4.2 Recent Industry Wide Strategic Developments
  • 4.2.1 Partnerships, Collaborations and Agreements
  • 4.2.2 Product Launches and Product Expansions
  • 4.2.3 Acquisition and Mergers
• 4.3 Market Share Analysis, 2023
• 4.4 Top Winning Strategies
  • 4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
• 4.5 Porter Five Forces Analysis

Chapter 5. Global Biological Data Visualization Market by Technique

• 5.1 Global Sequencing Market by Region
• 5.2 Global Microscopy Market by Region
• 5.3 Global Magnetic Resonance Imaging (MRI) Market by Region
• 5.4 Global X-ray Crystallography Market by Region
• 5.5 Global Other Technique Market by Region

Chapter 6. Global Biological Data Visualization Market by Platform

• 6.1 Global Windows Market by Region
• 6.2 Global Mac OS Market by Region
• 6.3 Global Linux Market by Region
• 6.4 Global Other Platform Market by Region

Chapter 7. Global Biological Data Visualization Market by Application

• 7.1 Global Cell & Organism Imaging Market by Region
• 7.2 Global Alignment, Phylogeny, & Evolution Market by Region
• 7.3 Global Genomic Analysis Market by Region
• 7.4 Global System Biology Market by Region
• 7.5 Global Structural Biology & Molecular Modeling Market by Region

Chapter 8. Global Biological Data Visualization Market by End Use

• 8.1 Global Academic Research Market by Region
• 8.2 Global Pharmaceutical & Biotechnology Companies Market by Region
• 8.3 Global Hospitals & Clinics Market by Region
• 8.4 Global Other End Use Market by Region

Chapter 9. Global Biological Data Visualization Market by Region

• 9.1 North America Biological Data Visualization Market
  • 9.1.1 North America Biological Data Visualization Market by Technique
    • 9.1.1.1 North America Sequencing Market by Region
    • 9.1.1.2 North America Microscopy Market by Region
    • 9.1.1.3 North America Magnetic Resonance Imaging (MRI) Market by Region
    • 9.1.1.4 North America X-ray Crystallography Market by Region
    • 9.1.1.5 North America Other Technique Market by Region
  • 9.1.2 North America Biological Data Visualization Market by Platform
    • 9.1.2.1 North America Windows Market by Country
    • 9.1.2.2 North America Mac OS Market by Country
    • 9.1.2.3 North America Linux Market by Country
    • 9.1.2.4 North America Other Platform Market by Country
  • 9.1.3 North America Biological Data Visualization Market by Application
    • 9.1.3.1 North America Cell & Organism Imaging Market by Country
    • 9.1.3.2 North America Alignment, Phylogeny, & Evolution Market by Country
    • 9.1.3.3 North America Genomic Analysis Market by Country
    • 9.1.3.4 North America System Biology Market by Country
    • 9.1.3.5 North America Structural Biology & Molecular Modeling Market by Country
  • 9.1.4 North America Biological Data Visualization Market by End Use
    • 9.1.4.1 North America Academic Research Market by Country
    • 9.1.4.2 North America Pharmaceutical & Biotechnology Companies Market by Country
    • 9.1.4.3 North America Hospitals & Clinics Market by Country
    • 9.1.4.4 North America Other End Use Market by Country
  • 9.1.5 North America Biological Data Visualization Market by Country
    • 9.1.5.1 US Biological Data Visualization Market
      • 9.1.5.1.1 US Biological Data Visualization Market by Technique
      • 9.1.5.1.2 US Biological Data Visualization Market by Platform
      • 9.1.5.1.3 US Biological Data Visualization Market by Application
      • 9.1.5.1.4 US Biological Data Visualization Market by End Use
    • 9.1.5.2 Canada Biological Data Visualization Market
      • 9.1.5.2.1 Canada Biological Data Visualization Market by Technique
      • 9.1.5.2.2 Canada Biological Data Visualization Market by Platform
      • 9.1.5.2.3 Canada Biological Data Visualization Market by Application
      • 9.1.5.2.4 Canada Biological Data Visualization Market by End Use
    • 9.1.5.3 Mexico Biological Data Visualization Market
      • 9.1.5.3.1 Mexico Biological Data Visualization Market by Technique
      • 9.1.5.3.2 Mexico Biological Data Visualization Market by Platform
      • 9.1.5.3.3 Mexico Biological Data Visualization Market by Application
      • 9.1.5.3.4 Mexico Biological Data Visualization Market by End Use
    • 9.1.5.4 Rest of North America Biological Data Visualization Market
      • 9.1.5.4.1 Rest of North America Biological Data Visualization Market by Technique
      • 9.1.5.4.2 Rest of North America Biological Data Visualization Market by Platform
      • 9.1.5.4.3 Rest of North America Biological Data Visualization Market by Application
      • 9.1.5.4.4 Rest of North America Biological Data Visualization Market by End Use
• 9.2 Europe Biological Data Visualization Market
  • 9.2.1 Europe Biological Data Visualization Market by Technique
    • 9.2.1.1 Europe Sequencing Market by Country
    • 9.2.1.2 Europe Microscopy Market by Country
    • 9.2.1.3 Europe Magnetic Resonance Imaging (MRI) Market by Country
    • 9.2.1.4 Europe X-ray Crystallography Market by Country
    • 9.2.1.5 Europe Other Technique Market by Country
  • 9.2.2 Europe Biological Data Visualization Market by Platform
    • 9.2.2.1 Europe Windows Market by Country
    • 9.2.2.2 Europe Mac OS Market by Country
    • 9.2.2.3 Europe Linux Market by Country
    • 9.2.2.4 Europe Other Platform Market by Country
  • 9.2.3 Europe Biological Data Visualization Market by Application
    • 9.2.3.1 Europe Cell & Organism Imaging Market by Country
    • 9.2.3.2 Europe Alignment, Phylogeny, & Evolution Market by Country
    • 9.2.3.3 Europe Genomic Analysis Market by Country
    • 9.2.3.4 Europe System Biology Market by Country
    • 9.2.3.5 Europe Structural Biology & Molecular Modeling Market by Country
  • 9.2.4 Europe Biological Data Visualization Market by End Use
    • 9.2.4.1 Europe Academic Research Market by Country
    • 9.2.4.2 Europe Pharmaceutical & Biotechnology Companies Market by Country
    • 9.2.4.3 Europe Hospitals & Clinics Market by Country
    • 9.2.4.4 Europe Other End Use Market by Country
  • 9.2.5 Europe Biological Data Visualization Market by Country
    • 9.2.5.1 Germany Biological Data Visualization Market
      • 9.2.5.1.1 Germany Biological Data Visualization Market by Technique
      • 9.2.5.1.2 Germany Biological Data Visualization Market by Platform
      • 9.2.5.1.3 Germany Biological Data Visualization Market by Application
      • 9.2.5.1.4 Germany Biological Data Visualization Market by End Use
    • 9.2.5.2 UK Biological Data Visualization Market
      • 9.2.5.2.1 UK Biological Data Visualization Market by Technique
      • 9.2.5.2.2 UK Biological Data Visualization Market by Platform
      • 9.2.5.2.3 UK Biological Data Visualization Market by Application
      • 9.2.5.2.4 UK Biological Data Visualization Market by End Use
    • 9.2.5.3 France Biological Data Visualization Market
      • 9.2.5.3.1 France Biological Data Visualization Market by Technique
      • 9.2.5.3.2 France Biological Data Visualization Market by Platform
      • 9.2.5.3.3 France Biological Data Visualization Market by Application
      • 9.2.5.3.4 France Biological Data Visualization Market by End Use
    • 9.2.5.4 Russia Biological Data Visualization Market
      • 9.2.5.4.1 Russia Biological Data Visualization Market by Technique
      • 9.2.5.4.2 Russia Biological Data Visualization Market by Platform
      • 9.2.5.4.3 Russia Biological Data Visualization Market by Application
      • 9.2.5.4.4 Russia Biological Data Visualization Market by End Use
    • 9.2.5.5 Spain Biological Data Visualization Market
      • 9.2.5.5.1 Spain Biological Data Visualization Market by Technique
      • 9.2.5.5.2 Spain Biological Data Visualization Market by Platform
      • 9.2.5.5.3 Spain Biological Data Visualization Market by Application
      • 9.2.5.5.4 Spain Biological Data Visualization Market by End Use
    • 9.2.5.6 Italy Biological Data Visualization Market
      • 9.2.5.6.1 Italy Biological Data Visualization Market by Technique
      • 9.2.5.6.2 Italy Biological Data Visualization Market by Platform
      • 9.2.5.6.3 Italy Biological Data Visualization Market by Application
      • 9.2.5.6.4 Italy Biological Data Visualization Market by End Use
    • 9.2.5.7 Rest of Europe Biological Data Visualization Market
      • 9.2.5.7.1 Rest of Europe Biological Data Visualization Market by Technique
      • 9.2.5.7.2 Rest of Europe Biological Data Visualization Market by Platform
      • 9.2.5.7.3 Rest of Europe Biological Data Visualization Market by Application
      • 9.2.5.7.4 Rest of Europe Biological Data Visualization Market by End Use
• 9.3 Asia Pacific Biological Data Visualization Market
  • 9.3.1 Asia Pacific Biological Data Visualization Market by Technique
    • 9.3.1.1 Asia Pacific Sequencing Market by Country
    • 9.3.1.2 Asia Pacific Microscopy Market by Country
    • 9.3.1.3 Asia Pacific Magnetic Resonance Imaging (MRI) Market by Country
    • 9.3.1.4 Asia Pacific X-ray Crystallography Market by Country
    • 9.3.1.5 Asia Pacific Other Technique Market by Country
  • 9.3.2 Asia Pacific Biological Data Visualization Market by Platform
    • 9.3.2.1 Asia Pacific Windows Market by Country
    • 9.3.2.2 Asia Pacific Mac OS Market by Country
    • 9.3.2.3 Asia Pacific Linux Market by Country
    • 9.3.2.4 Asia Pacific Other Platform Market by Country
  • 9.3.3 Asia Pacific Biological Data Visualization Market by Application
    • 9.3.3.1 Asia Pacific Cell & Organism Imaging Market by Country
    • 9.3.3.2 Asia Pacific Alignment, Phylogeny, & Evolution Market by Country
    • 9.3.3.3 Asia Pacific Genomic Analysis Market by Country
    • 9.3.3.4 Asia Pacific System Biology Market by Country
    • 9.3.3.5 Asia Pacific Structural Biology & Molecular Modeling Market by Country
  • 9.3.4 Asia Pacific Biological Data Visualization Market by End Use
    • 9.3.4.1 Asia Pacific Academic Research Market by Country
    • 9.3.4.2 Asia Pacific Pharmaceutical & Biotechnology Companies Market by Country
    • 9.3.4.3 Asia Pacific Hospitals & Clinics Market by Country
    • 9.3.4.4 Asia Pacific Other End Use Market by Country
  • 9.3.5 Asia Pacific Biological Data Visualization Market by Country
    • 9.3.5.1 China Biological Data Visualization Market
      • 9.3.5.1.1 China Biological Data Visualization Market by Technique
      • 9.3.5.1.2 China Biological Data Visualization Market by Platform
      • 9.3.5.1.3 China Biological Data Visualization Market by Application
      • 9.3.5.1.4 China Biological Data Visualization Market by End Use
    • 9.3.5.2 Japan Biological Data Visualization Market
      • 9.3.5.2.1 Japan Biological Data Visualization Market by Technique
      • 9.3.5.2.2 Japan Biological Data Visualization Market by Platform
      • 9.3.5.2.3 Japan Biological Data Visualization Market by Application
      • 9.3.5.2.4 Japan Biological Data Visualization Market by End Use
    • 9.3.5.3 India Biological Data Visualization Market
      • 9.3.5.3.1 India Biological Data Visualization Market by Technique
      • 9.3.5.3.2 India Biological Data Visualization Market by Platform
      • 9.3.5.3.3 India Biological Data Visualization Market by Application
      • 9.3.5.3.4 India Biological Data Visualization Market by End Use
    • 9.3.5.4 South Korea Biological Data Visualization Market
      • 9.3.5.4.1 South Korea Biological Data Visualization Market by Technique
      • 9.3.5.4.2 South Korea Biological Data Visualization Market by Platform
      • 9.3.5.4.3 South Korea Biological Data Visualization Market by Application
      • 9.3.5.4.4 South Korea Biological Data Visualization Market by End Use
    • 9.3.5.5 Singapore Biological Data Visualization Market
      • 9.3.5.5.1 Singapore Biological Data Visualization Market by Technique
      • 9.3.5.5.2 Singapore Biological Data Visualization Market by Platform
      • 9.3.5.5.3 Singapore Biological Data Visualization Market by Application
      • 9.3.5.5.4 Singapore Biological Data Visualization Market by End Use
    • 9.3.5.6 Malaysia Biological Data Visualization Market
      • 9.3.5.6.1 Malaysia Biological Data Visualization Market by Technique
      • 9.3.5.6.2 Malaysia Biological Data Visualization Market by Platform
      • 9.3.5.6.3 Malaysia Biological Data Visualization Market by Application
      • 9.3.5.6.4 Malaysia Biological Data Visualization Market by End Use
    • 9.3.5.7 Rest of Asia Pacific Biological Data Visualization Market
      • 9.3.5.7.1 Rest of Asia Pacific Biological Data Visualization Market by Technique
      • 9.3.5.7.2 Rest of Asia Pacific Biological Data Visualization Market by Platform
      • 9.3.5.7.3 Rest of Asia Pacific Biological Data Visualization Market by Application
      • 9.3.5.7.4 Rest of Asia Pacific Biological Data Visualization Market by End Use
• 9.4 LAMEA Biological Data Visualization Market
  • 9.4.1 LAMEA Biological Data Visualization Market by Technique
    • 9.4.1.1 LAMEA Sequencing Market by Country
    • 9.4.1.2 LAMEA Microscopy Market by Country
    • 9.4.1.3 LAMEA Magnetic Resonance Imaging (MRI) Market by Country
    • 9.4.1.4 LAMEA X-ray Crystallography Market by Country
    • 9.4.1.5 LAMEA Other Technique Market by Country
  • 9.4.2 LAMEA Biological Data Visualization Market by Platform
    • 9.4.2.1 LAMEA Windows Market by Country
    • 9.4.2.2 LAMEA Mac OS Market by Country
    • 9.4.2.3 LAMEA Linux Market by Country
    • 9.4.2.4 LAMEA Other Platform Market by Country
  • 9.4.3 LAMEA Biological Data Visualization Market by Application
    • 9.4.3.1 LAMEA Cell & Organism Imaging Market by Country
    • 9.4.3.2 LAMEA Alignment, Phylogeny, & Evolution Market by Country
    • 9.4.3.3 LAMEA Genomic Analysis Market by Country
    • 9.4.3.4 LAMEA System Biology Market by Country
    • 9.4.3.5 LAMEA Structural Biology & Molecular Modeling Market by Country
  • 9.4.4 LAMEA Biological Data Visualization Market by End Use
    • 9.4.4.1 LAMEA Academic Research Market by Country
    • 9.4.4.2 LAMEA Pharmaceutical & Biotechnology Companies Market by Country
    • 9.4.4.3 LAMEA Hospitals & Clinics Market by Country
    • 9.4.4.4 LAMEA Other End Use Market by Country
  • 9.4.5 LAMEA Biological Data Visualization Market by Country
    • 9.4.5.1 Brazil Biological Data Visualization Market
      • 9.4.5.1.1 Brazil Biological Data Visualization Market by Technique
      • 9.4.5.1.2 Brazil Biological Data Visualization Market by Platform
      • 9.4.5.1.3 Brazil Biological Data Visualization Market by Application
      • 9.4.5.1.4 Brazil Biological Data Visualization Market by End Use
    • 9.4.5.2 Argentina Biological Data Visualization Market
      • 9.4.5.2.1 Argentina Biological Data Visualization Market by Technique
      • 9.4.5.2.2 Argentina Biological Data Visualization Market by Platform
      • 9.4.5.2.3 Argentina Biological Data Visualization Market by Application
      • 9.4.5.2.4 Argentina Biological Data Visualization Market by End Use
    • 9.4.5.3 UAE Biological Data Visualization Market
      • 9.4.5.3.1 UAE Biological Data Visualization Market by Technique
      • 9.4.5.3.2 UAE Biological Data Visualization Market by Platform
      • 9.4.5.3.3 UAE Biological Data Visualization Market by Application
      • 9.4.5.3.4 UAE Biological Data Visualization Market by End Use
    • 9.4.5.4 Saudi Arabia Biological Data Visualization Market
      • 9.4.5.4.1 Saudi Arabia Biological Data Visualization Market by Technique
      • 9.4.5.4.2 Saudi Arabia Biological Data Visualization Market by Platform
      • 9.4.5.4.3 Saudi Arabia Biological Data Visualization Market by Application
      • 9.4.5.4.4 Saudi Arabia Biological Data Visualization Market by End Use
    • 9.4.5.5 South Africa Biological Data Visualization Market
      • 9.4.5.5.1 South Africa Biological Data Visualization Market by Technique
      • 9.4.5.5.2 South Africa Biological Data Visualization Market by Platform
      • 9.4.5.5.3 South Africa Biological Data Visualization Market by Application
      • 9.4.5.5.4 South Africa Biological Data Visualization Market by End Use
    • 9.4.5.6 Nigeria Biological Data Visualization Market
      • 9.4.5.6.1 Nigeria Biological Data Visualization Market by Technique
      • 9.4.5.6.2 Nigeria Biological Data Visualization Market by Platform
      • 9.4.5.6.3 Nigeria Biological Data Visualization Market by Application
      • 9.4.5.6.4 Nigeria Biological Data Visualization Market by End Use
    • 9.4.5.7 Rest of LAMEA Biological Data Visualization Market
      • 9.4.5.7.1 Rest of LAMEA Biological Data Visualization Market by Technique
      • 9.4.5.7.2 Rest of LAMEA Biological Data Visualization Market by Platform
      • 9.4.5.7.3 Rest of LAMEA Biological Data Visualization Market by Application
      • 9.4.5.7.4 Rest of LAMEA Biological Data Visualization Market by End Use

Chapter 10. Company Profiles

• 10.1 Thermo Fisher Scientific, Inc.
  • 10.1.1 Company Overview
  • 10.1.2 Financial Analysis
  • 10.1.3 Segmental and Regional Analysis
  • 10.1.4 Research & Development Expenses
  • 10.1.5 Recent strategies and developments:
    • 10.1.5.1 Product Launches and Product Expansions:
  • 10.1.6 SWOT Analysis
• 10.2 3M Company
  • 10.2.1 Company Overview
  • 10.2.2 Financial Analysis
  • 10.2.3 Segmental and Regional Analysis
  • 10.2.4 Research & Development Expense
  • 10.2.5 SWOT Analysis
• 10.3 Agilent Technologies, Inc.
  • 10.3.1 Company Overview
  • 10.3.2 Financial Analysis
  • 10.3.3 Segmental and Regional Analysis
  • 10.3.4 Research & Development Expense
  • 10.3.5 Recent strategies and developments:
    • 10.3.5.1 Partnerships, Collaborations, and Agreements:
    • 10.3.5.2 Acquisition and Mergers:
  • 10.3.6 SWOT Analysis
• 10.4 Bio-Rad laboratories, Inc.
  • 10.4.1 Company Overview
  • 10.4.2 Financial Analysis
  • 10.4.3 Segmental and Regional Analysis
  • 10.4.4 Research & Development Expenses
  • 10.4.5 SWOT Analysis
• 10.5 Illumina, Inc.
  • 10.5.1 Company Overview
  • 10.5.2 Financial Analysis
  • 10.5.3 Segment and Regional Analysis
  • 10.5.4 Research & Development Expense
  • 10.5.5 Recent strategies and developments:
    • 10.5.5.1 Product Launches and Product Expansions:
  • 10.5.6 SWOT Analysis
• 10.6 Revvity, Inc.
  • 10.6.1 Company Overview
  • 10.6.2 Financial Analysis
  • 10.6.3 Segmental and Regional Analysis
  • 10.6.4 Research & Development Expenses
  • 10.6.5 Recent strategies and developments:
    • 10.6.5.1 Partnerships, Collaborations, and Agreements:
    • 10.6.5.2 Product Launches and Product Expansions:
  • 10.6.6 SWOT Analysis
• 10.7 Qiagen N.V.
  • 10.7.1 Company Overview
  • 10.7.2 Financial Analysis
  • 10.7.3 Regional Analysis
  • 10.7.4 Research & Development Expenses
  • 10.7.5 Recent strategies and developments:
    • 10.7.5.1 Product Launches and Product Expansions:
  • 10.7.6 SWOT Analysis
• 10.8 Carl Zeiss AG
  • 10.8.1 Company Overview
  • 10.8.2 Financial Analysis
  • 10.8.3 Segmental and Regional Analysis
  • 10.8.4 Research & Development Expenses
  • 10.8.5 Recent strategies and developments:
    • 10.8.5.1 Partnerships, Collaborations, and Agreements:
  • 10.8.6 SWOT Analysis
• 10.9 Oxford Instruments plc
  • 10.9.1 Company Overview
  • 10.9.2 Financial Analysis
  • 10.9.3 Segmental and Regional Analysis
  • 10.9.4 Research & Development Expenses
  • 10.9.5 Recent strategies and developments:
    • 10.9.5.1 Acquisition and Mergers:
• 10.10. Olympus Corporation
  • 10.10.1 Company Overview
  • 10.10.2 Financial Analysis
  • 10.10.3 Segmental and Regional Analysis
  • 10.10.4 SWOT Analysis

Chapter 11. Winning Imperatives of Biological Data Visualization Market